BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2016
View Archived Issues
vTv Therapeutics describes HK-2 inhibitors
Read More
SAMHD1, a novel biomarker for cytarabine response and therapeutic target in AML
Read More
Ebola vaccine rVSV-ZEBOV shows promising results in clinical trial
Read More
Pharmacyclics patents BTK inhibitors
Read More
Merck & Co. and MSD R&D disclose PDE2A inhibitors
Read More
OncoMed Pharmaceuticals reports phase Ia results on OMP-305B83
Read More
Scientists report phase II data for selinexor in patients with MM
Read More
Investigators present preliminary phase II results of SL-401 in AML patients
Read More
BAX-930 shows potential in patients with hereditary thrombotic thrombocytopenic purpura
Read More
Columbia University Medical Center sponsors clinical study using Biocept's liquid biopsy platform
Read More
FDA expands indications for Shire's Adynovate
Read More
NIPTE forms part of a newly announced National Biopharmaceutical Manufacturing Institute
Read More
Prana offers update on development portfolio
Read More
Bioinformatics confirms GM6 as a regulator of ALS- and AD- relevant pathways
Read More
DynPort Vaccine Company receives contract to help advance medical products for NIAID
Read More
Capnia and Essentialis sign merger agreement
Read More
World's only recombinant monovalent acellular Pertussis vaccine receives Thai FDA approval
Read More
Anthera reports topline data from phase III study of Sollpura
Read More
FDA puts clinical hold on several early-stage trials of vadastuximab talirine
Read More
OSE Immunotherapeutics signs worldwide license option agreement with Servier for Effi-7
Read More
U.S. and China IND clearances for Ascentage's APG-1252
Read More
Ono seeks Japanese approval of Opdivo in gastric cancer
Read More
Phase III results for padeliporfin vascular-targeted photodynamic therapy in prostate cancer
Read More
Immunomedics' phase II study of sacituzumab govitecan reaches planned enrollment
Read More
Escend Pharmaceuticals' tetrandrine gets FDA orphan designation for AML
Read More